Frondoside A suppressive effects on lung cancer survival, tumor growth, angiogenesis, invasion, and metastasis

A major challenge for oncologists and pharmacologists is to develop less toxic drugs that will improve the survival of lung cancer patients. Frondoside A is a triterpenoid glycoside isolated from the sea cucumber, Cucumaria frondosa and was shown to be a highly safe compound. We investigated the imp...

Full description

Bibliographic Details
Published in:PLoS ONE
Main Authors: Attoub, Samir, Arafat, Kholoud, Gelaude, An, Al Sultan, Mahmood Ahmed, Bracke, Marc, Collin, Peter, Takahashi, Takashi, Adrian, Thomas E, De Wever, Olivier
Format: Article in Journal/Newspaper
Language:English
Published: 2013
Subjects:
Medicine and Health Sciences
SEA-CUCUMBER
CUCUMARIA-FRONDOSA
TRITERPENE GLYCOSIDE
PANCREATIC-CANCER
NATURAL-PRODUCTS
DRUG DEVELOPMENT
EXTRACT
Cucumaria frondosa
Online Access:https://biblio.ugent.be/publication/4328495
http://hdl.handle.net/1854/LU-4328495
https://doi.org/10.1371/journal.pone.0053087
https://biblio.ugent.be/publication/4328495/file/4328680
Description
Summary:A major challenge for oncologists and pharmacologists is to develop less toxic drugs that will improve the survival of lung cancer patients. Frondoside A is a triterpenoid glycoside isolated from the sea cucumber, Cucumaria frondosa and was shown to be a highly safe compound. We investigated the impact of Frondoside A on survival, migration and invasion in vitro, and on tumor growth, metastasis and angiogenesis in vivo alone and in combination with cisplatin. Frondoside A caused concentration-dependent reduction in viability of LNM35, A549, NCI-H460-Luc2, MDA-MB-435, MCF-7, and HepG2 over 24 hours through a caspase 3/7-dependent cell death pathway. The IC50 concentrations (producing half-maximal inhibition) at 24 h were between 1.7 and 2.5 mu M of Frondoside A. In addition, Frondoside A induced a time- and concentration-dependent inhibition of cell migration, invasion and angiogenesis in vitro. Frondoside A (0.01 and 1 mg/kg/day i.p. for 25 days) significantly decreased the growth, the angiogenesis and lymph node metastasis of LNM35 tumor xenografts in athymic mice, without obvious toxic side-effects. Frondoside A (0.1-0.5 mu M) also significantly prevented basal and bFGF induced angiogenesis in the CAM angiogenesis assay. Moreover, Frondoside A enhanced the inhibition of lung tumor growth induced by the chemotherapeutic agent cisplatin. These findings identify Frondoside A as a promising novel therapeutic agent for lung cancer.

Similar Items